OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Laboratory Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Molecular Detection of Oncogenic Gene Rearrangements	24
Contents	23
Current Topics in Molecular Diagnostics and Precision Medicine	22
Contributors	19
Molecular Pathology of Ovarian Epithelial Neoplasms	18
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists	13
Digital Imaging and AI Pre-classification in Hematology	12
Promoting Health Equity Through Effective Laboratory Stewardship Strategies	12
Is It Possible to Test for Viral Infectiousness?	11
Contributors	10
Inclusive Laboratory Reference Intervals and Clinical Studies to Reduce Health Disparities	10
Molecular Oncology Diagnostics	10
Copy Number Analysis in Cancer Diagnostic Testing	10
Automated Quality Assurance Rules for Liquid Chromatography–Mass Spectrometry Testing in a Clinical Laboratory	9
Infant Acute Leukemia	9
Point-of-Care Drug Testing	9
Gene Rearrangement Detection in Pediatric Leukemia	9
Hematopathologic Correlates of CAR T-Cell Therapy	8
Leadership's Role in Paving the Path to Diversity, Equity, and Inclusion in Laboratory Medicine	8
Contributors	8
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation	8
Role of Minimal Residual Disease Testing in Acute Myeloid Leukemia	7
Nothing Basic About It: Guiding the Judicious Use of Diagnostic Tests	7
Opportunities and Challenges with Artificial Intelligence in Genomics	7
Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders	7

Contents	7
Contributors	7
Cell-free Nucleic Acids in Cancer	7
Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management	7
Contextualizing Race and Ethnicity in the Practice of Laboratory Medicine	6
Leadership Approaches for Work-Life Balance, Well-Being, and Diversity, Equity, and Inclusion Support in the Laboratory	6
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53	6
Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology	6
Artificial Intelligence for Clinical Flow Cytometry	6
Flow Cytometry and Platelets	6
Update on Acute Leukemias of Ambiguous Lineage	5
Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19	5
The Evolving Role of Molecular Diagnostics in Pathology	5
The Impact of Inclusive Excellence Initiatives on Laboratory Wellness	5
Electronic Health Record Optimization for Artificial Intelligence	5
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing	5
Copyright	5
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe	5
Molecular Diagnostics for Invasive Molds: From Lab to Bedside	5
Molecular Biomarkers of Response to Cancer Immunotherapy	5
Contents	5
Morphologic Characteristics of Myelodysplastic Syndromes	5
Steps Forward to a Fair and Inclusive Blood Supply	5
Copyright	5
Molecular Alterations in Pediatric Solid Tumors	5
The Mass Spectrometry Revolution in Clinical Microbiology Part 2	4
Contributors	4
Transfusion Medicine Informatics	4
Utility of Single-Gene Testing in Cancer Specimens	4
Artificial Intelligence in the Clinical Laboratory	4
Copyright	4
Diagnostic Stewardship for Multiplex Respiratory Testing	4
Point of Care Molecular Testing	4
Rapid Antigen Assays for SARS-CoV-2	4
Taking Center Stage	4
Contents	4
Copyright	4
Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)	4
Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation	3
Transfusion Reactions and Adverse Events	3
Copyright	3
Reactive Lymphadenopathies	3
Molecular Pathology of Breast Tumors	3
Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility	3
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2	3
Update on Ovarian Sex Cord–Stromal Tumors	3
Molecular Methods	3
Updates in Blood Banking and Transfusion Medicine	3
Value of Improving Result Interpretation in Direct-to-Definitive Urine Drug Panels	3
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology	3

A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults	3
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms	3
Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia	3
Childhood Myelodysplastic Syndrome	3